Cargando…

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy

Detalles Bibliográficos
Autores principales:	Pugh, R, Hampshire, P, Hajimichael, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642956/ http://dx.doi.org/10.1186/cc12453

Ejemplares similares

Outcome of critically ill patients with haematological malignancy admitted to the ICU as an emergency
por: Lofaro, T, et al.
Publicado: (2013)

Predictors of outcome in patients with haematological malignancies admitted to critical care
por: Tridente, A, et al.
Publicado: (2014)

Is intensive care beneficial for patients with haematologic malignancies?
por: Nyunga, M, et al.
Publicado: (2010)

The outcome of patients admitted to an intensive care unit with haematological malignancy: a case–control study
por: Hampshire, P, et al.
Publicado: (2007)

Prognosis of patients with haematological malignancies admitted to the ICU
por: Geerse, DA, et al.
Publicado: (2008)

Outcome of patients with haematological malignancy admitted to the general ICU
por: Ketchley, I, et al.
Publicado: (2008)

Advance care planning in critically ill haematology patients
por: Metaxa, V, et al.
Publicado: (2014)

Outcome of patients with metastatic cancer or haematological malignancy in intensive care
por: Meynaar, I, et al.
Publicado: (2009)

Survival rate and predictors of outcome in intubated patients with haematological malignancies in a Greek ICU
por: Tsolaki, V, et al.
Publicado: (2014)

Prediction of hospital mortality by classification trees and smoothing splines in patients with haematological malignancies admitted to the ICU
por: Verplancke, T, et al.
Publicado: (2009)

Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014)

P631 Community respiratory virus infections in patients with haematological malignancies
por: Chebotkevich, V., et al.
Publicado: (2007)

PSYCHOLOGICAL ASPECTS OF HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, P., et al.
Publicado: (1990)

Prediction of hospital mortality by support vector machine versus logistic regression in patients with a haematological malignancy admitted to the ICU
por: Verplancke, T, et al.
Publicado: (2008)

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2011)

Outcome of haematology patients admitted to intensive care in a tertiary centre: primary haematological diagnosis, recent chemotherapy and bone marrow transplantation are not associated with outcome
por: José, R, et al.
Publicado: (2011)

Outcome prediction in haematological patients requiring admission to the ICU
por: Gopal, S, et al.
Publicado: (2011)

Patterns of infection and impact on outcome in haematology patients admitted to intensive care
por: José, R, et al.
Publicado: (2011)

Beta-D-Glucan in Patients with Haematological Malignancies
por: Mikulska, Malgorzata, et al.
Publicado: (2021)

Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies
por: Pei, Yuxin, et al.
Publicado: (2020)

Haematological patients admitted to icu: differences between survivors and non-survivors
por: Lujan Varas, J, et al.
Publicado: (2015)

Breast imaging findings in haematological malignancies
por: Glazebrook, K. N., et al.
Publicado: (2014)

P1570: SARS-COV-2 HUMORAL AND CELLULAR VACCINATION RESPONSE IN PATIENTS WITH LYMPHOID HAEMATOLOGICAL MALIGNANCIES
por: Boerenkamp, L. S., et al.
Publicado: (2022)

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
por: Sheridan, Rebecca, et al.
Publicado: (2021)

Non-transplant patients with haematologic malignancies have better survival outcome than recipients of haematopoietic stem cell transplant (HSCT) after admission to intensive care unit (ICU)
por: Corcia Palomo, Y, et al.
Publicado: (2015)

The Role of miRNA in Haematological Malignancy
por: Gounaris-Shannon, Stephanie, et al.
Publicado: (2013)

Expression of testicular genes in haematological malignancies
por: Lim, S H, et al.
Publicado: (1999)

Clinical use of rituximab in haematological malignancies
por: Avivi, I, et al.
Publicado: (2003)

Cancer stem cells in haematological malignancies
por: Zagozdzon, Radoslaw, et al.
Publicado: (2015)

The hypoxia signalling pathway in haematological malignancies
por: Irigoyen, Marta, et al.
Publicado: (2017)

The Application of CAR-T Cells in Haematological Malignancies
por: Skorka, Katarzyna, et al.
Publicado: (2020)

Clinical Proteomics of Biofluids in Haematological Malignancies
por: Dunphy, Katie, et al.
Publicado: (2021)

COVID-19 in children with haematological malignancies
por: Millen, Gerard Cathal, et al.
Publicado: (2022)

Targeting hypoxia in solid and haematological malignancies
por: Harris, Bill, et al.
Publicado: (2022)

Immune-epigenetic crosstalk in haematological malignancies
por: Wong, Hera, et al.
Publicado: (2023)

Con: Bronchoscopy is essential for pulmonary infections in patients with haematological malignancies
por: Ing, Matthew K., et al.
Publicado: (2020)

Is bronchoscopy essential for pulmonary infections in patients with haematological malignancies?
por: Harrington, Zinta
Publicado: (2020)

Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms
por: Vanni, Daniele, et al.
Publicado: (2022)

Early integration of palliative care for patients with haematological malignancies
por: Shaulov, Adir, et al.
Publicado: (2022)

P1727: EPIDEMIOLOGICAL TRENDS OF HAEMATOLOGICAL MALIGNANCIES IN BELGIUM 2004-2018: OLDER PATIENTS SHOWED THE GREATEST IMPROVED SURVIVAL OVER TIME
por: Henau, K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ffi5b3ad5qoptao2dvuq7r1lq1